Martine Zimmermann PharmD. is VP global Regulatory Affairs at Alexion. She is based in Zurich. She has over 20 years of combined R&D and global regulatory strategy experience. She joined Alexion in 2009 and since then has been dedicated to the registration of Orphan Medical products as well as shaping a favorable regulatory environment for orphans. Throughout her career, Martine has been directly involved in multiple regulatory approvals across the globe and most recently 2 enzyme replacement therapies for ultra-rare metabolic disease.
Martine received her Pharm D from University Louis Pasteur in Strasbourg (France).